[{"anchor":"km-mouse","group":"km","label":"Mouse Km divisor","value":"12.3","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.mouse"},{"anchor":"km-hamster","group":"km","label":"Hamster Km divisor","value":"7.4","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.hamster"},{"anchor":"km-rat","group":"km","label":"Rat Km divisor","value":"6.2","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.rat"},{"anchor":"km-ferret","group":"km","label":"Ferret Km divisor","value":"5.3","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.ferret"},{"anchor":"km-guinea_pig","group":"km","label":"Guinea pig Km divisor","value":"4.6","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.guinea_pig"},{"anchor":"km-rabbit","group":"km","label":"Rabbit Km divisor","value":"3.1","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.rabbit"},{"anchor":"km-dog","group":"km","label":"Dog Km divisor","value":"1.8","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.dog"},{"anchor":"km-monkey","group":"km","label":"Monkey Km divisor","value":"3.1","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.monkey"},{"anchor":"km-marmoset","group":"km","label":"Marmoset Km divisor","value":"6.2","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.marmoset"},{"anchor":"km-micropig","group":"km","label":"Micropig Km divisor","value":"1.4","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.micropig"},{"anchor":"km-minipig","group":"km","label":"Minipig Km divisor","value":"1.1","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.minipig"},{"anchor":"km-baboon","group":"km","label":"Baboon Km divisor","value":"1.8","context":"Animal-to-human body surface area conversion divisor (HED = NOAEL ÷ Km).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"Copied verbatim from the primary guidance table, not recalled from memory.","lastVerified":"2026-09-02","sourcePath":"species_km_divisor.baboon"},{"anchor":"body-weight-us","group":"body-weight","label":"US reference body weight","value":"60","unit":"kg","context":"FDA CDER 2005 default adult reference body weight.","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"FDA 2005 default adult reference body weight.","lastVerified":"2026-09-02","sourcePath":"regions.US"},{"anchor":"body-weight-eu","group":"body-weight","label":"EU reference body weight","value":"60","unit":"kg","context":"60 kg default retained for historical FDA/EMA back-calculation alignment; EMA 2017 does not codify a single reference BW. Editable per program.","citation":"No single EMA-codified reference body weight exists; retained for historical FDA/EMA back-calculation alignment.","issuingBody":"EMA (no single codified value)","publicationDate":"n/a","verification":"flagged","verificationNote":"Editable convention, not a codified regulatory value. Shown as flagged rather than presented as sourced.","lastVerified":"2026-09-02","sourcePath":"regions.EU"},{"anchor":"default-safety-factor","group":"safety-factor","label":"Default safety factor","value":"10","context":"Applied to the governing HED to derive the MRSD (MRSD = HED ÷ safety factor).","citation":"FDA Guidance for Industry (CDER, July 2005), \"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers,\" Table 1. Step 4.","issuingBody":"FDA / CDER","publicationDate":"2005-07","verification":"sourced","verificationNote":"FDA 2005 Step 4 default of 10, editable per program.","lastVerified":"2026-09-02","sourcePath":"default_safety_factor"},{"anchor":"ich-s9-rodent-fraction","group":"ich-s9","label":"ICH S9 rodent starting-dose fraction","value":"10%","context":"Fraction of STD10 used as the oncology starting dose for rodent-only programs.","citation":"ICH S9, \"Nonclinical Evaluation for Anticancer Pharmaceuticals.\"","issuingBody":"ICH","publicationDate":"unresolved","verification":"flagged","verificationNote":"Rule value is hard-coded from the engine's own build spec; the ICH S9 source text has not yet been extracted and cross-checked. Flagged, not presented as sourced.","lastVerified":"2026-09-02","sourcePath":"ich_s9.rodent_fraction"},{"anchor":"ich-s9-non-rodent-divisor","group":"ich-s9","label":"ICH S9 non-rodent HNSTD divisor","value":"6","context":"HNSTD is divided by this factor for non-rodent oncology programs.","citation":"ICH S9, \"Nonclinical Evaluation for Anticancer Pharmaceuticals.\"","issuingBody":"ICH","publicationDate":"unresolved","verification":"flagged","verificationNote":"Same status as the rodent fraction above: hard-coded from spec, not yet traced to the primary ICH text.","lastVerified":"2026-09-02","sourcePath":"ich_s9.non_rodent_divisor"},{"anchor":"dose-volume-mouse-oral","group":"dose-volume","label":"Mouse max dose volume, oral","value":"10","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.mouse.oral"},{"anchor":"dose-volume-mouse-intravenous","group":"dose-volume","label":"Mouse max dose volume, intravenous (bolus)","value":"5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.mouse.intravenous.bolus"},{"anchor":"dose-volume-mouse-intravenous-slow-infusion","group":"dose-volume","label":"Mouse max dose volume, intravenous (slow infusion)","value":"25","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-04","sourcePath":"dose_volume_max_ml_per_kg.mouse.intravenous.slow_infusion"},{"anchor":"dose-volume-mouse-intraperitoneal","group":"dose-volume","label":"Mouse max dose volume, intraperitoneal","value":"20","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.mouse.intraperitoneal"},{"anchor":"dose-volume-mouse-subcutaneous","group":"dose-volume","label":"Mouse max dose volume, subcutaneous","value":"10","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.mouse.subcutaneous"},{"anchor":"dose-volume-rat-oral","group":"dose-volume","label":"Rat max dose volume, oral","value":"10","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.rat.oral"},{"anchor":"dose-volume-rat-intravenous","group":"dose-volume","label":"Rat max dose volume, intravenous (bolus)","value":"5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.rat.intravenous.bolus"},{"anchor":"dose-volume-rat-intravenous-slow-infusion","group":"dose-volume","label":"Rat max dose volume, intravenous (slow infusion)","value":"20","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-04","sourcePath":"dose_volume_max_ml_per_kg.rat.intravenous.slow_infusion"},{"anchor":"dose-volume-rat-intraperitoneal","group":"dose-volume","label":"Rat max dose volume, intraperitoneal","value":"10","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.rat.intraperitoneal"},{"anchor":"dose-volume-rat-subcutaneous","group":"dose-volume","label":"Rat max dose volume, subcutaneous","value":"5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.rat.subcutaneous"},{"anchor":"dose-volume-dog-oral","group":"dose-volume","label":"Dog max dose volume, oral","value":"5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.dog.oral"},{"anchor":"dose-volume-dog-intravenous","group":"dose-volume","label":"Dog max dose volume, intravenous (bolus)","value":"2.5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.dog.intravenous.bolus"},{"anchor":"dose-volume-dog-intravenous-slow-infusion","group":"dose-volume","label":"Dog max dose volume, intravenous (slow infusion)","value":"5","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-04","sourcePath":"dose_volume_max_ml_per_kg.dog.intravenous.slow_infusion"},{"anchor":"dose-volume-dog-subcutaneous","group":"dose-volume","label":"Dog max dose volume, subcutaneous","value":"1","unit":"mL/kg","citation":"Diehl et al., 2001, published industry dose-volume defaults.","issuingBody":"Diehl et al. (2001), industry consensus","publicationDate":"2001","verification":"flagged","verificationNote":"Published industry default, not yet mirrored into the primary-source wiki. The audit payload advises IACUC SOP confirmation before use.","lastVerified":"2026-09-02","sourcePath":"dose_volume_max_ml_per_kg.dog.subcutaneous"},{"anchor":"mabel-ec50-anchor-fraction","group":"mabel","label":"MABEL EC50/IC50 anchor fraction","value":"10%","context":"Default fraction of in vitro functional EC50/IC50 used to anchor the MABEL EC50-based mode.","citation":"EMA guideline EMEA/CHMP/SWP/28367/07 Rev. 1 (July 2017) — the guidance the MABEL module is built against.","issuingBody":"EMA","publicationDate":"2017-07","verification":"flagged","verificationNote":"An engine default from its own build spec for the EC50-based MABEL mode; the engine's decision log calls this module's math a documented stub pending full target-engagement PK/PD modeling. Tracing it would need the specific fraction extracted from the primary EMA 2017 text into the engine's own wiki, not just the guidance named as the module's general basis.","lastVerified":"2026-09-04","sourcePath":"mabel_default_ec50_anchor_fraction"},{"anchor":"mabel-default-vd","group":"mabel","label":"MABEL default volume of distribution","value":"0.07","unit":"L/kg","context":"Assumed volume of distribution multiplied against the EC50/IC50 anchor fraction in the MABEL EC50-based mode.","citation":"EMA guideline EMEA/CHMP/SWP/28367/07 Rev. 1 (July 2017) — the guidance the MABEL module is built against.","issuingBody":"EMA","publicationDate":"2017-07","verification":"flagged","verificationNote":"Same stub status as the anchor fraction above: a single hard-coded default rather than a species- or program-specific value drawn from a primary Vd source. Tracing it would need that program-specific source, not one constant.","lastVerified":"2026-09-04","sourcePath":"mabel_default_vd_l_per_kg"},{"anchor":"cell-therapy-default-safety-factor","group":"cell-therapy","label":"Cell therapy default safety factor","value":"10","context":"Applied to the nonclinical potency benchmark to derive the cell therapy starting dose.","citation":"No single codified cell-therapy safety-factor guidance is cited by the engine for this default.","issuingBody":"Not regulatory — engine default","publicationDate":"n/a","verification":"flagged","verificationNote":"An engine default from its own build spec for the Cell Therapy Starting Dose module, not drawn from a cell-therapy-specific dosing guidance the engine's documentation names. Tracing it would need a primary cell-therapy safety-factor reference, which the engine's own documentation does not yet cite.","lastVerified":"2026-09-04","sourcePath":"cell_therapy_default_sf"},{"anchor":"cell-therapy-precedent-fraction","group":"cell-therapy","label":"Cell therapy precedent-dose fraction","value":"10%","context":"Default fraction of the clinical-precedent dose used when the module's dose mode is precedent-based.","citation":"No single codified cell-therapy precedent-fraction guidance is cited by the engine for this default.","issuingBody":"Not regulatory — engine default","publicationDate":"n/a","verification":"flagged","verificationNote":"Same status as the safety factor above: an engine default from its own build spec, not yet traced to a primary cell-therapy reference.","lastVerified":"2026-09-04","sourcePath":"cell_therapy_default_precedent_fraction"}]